. 2018 Jun 1;18(2):1271–1278. doi: 10.3892/mmr.2018.9122

Table I.

Expression of claudin-2 and claudin-5, and the clinicopathological characteristics in patients with gastric carcinoma.

Factor	n	Claudin-2 (high)	Claudin-2 (low)	P-value	n	Claudin-5 (high)	Claudin-5 (low)	P-value
Gastric carcinoma tissue	100	37	63	0.374	100	47	53	<0.01
Non-neoplastic tissue	100	41	59		100	19	81
Age, years
≤60	29	10	19	1.000^a	27	15	12	0.261^a
>60	71	27	44		73	32	41
Histological grade
Well-differentiated	35	12	23	1.000^a	32	16	16	0.614^a
Moderately and poorly-differentiated	65	25	40		68	31	37
Lymph node metastasis
+	46	16	30	0.368	39	15	24	<0.01
−	64	21	43		61	32	29
Ki67
+	29	11	18	0.232^a	27	12	15	0.443^a
−	71	26	45		73	35	38
Clinical stage
I–II	27	11	16	1.000^a	27	15	12	0.863^a
III–IV	73	26	57		73	32	41

No statistical significance was observed with the χ² test/χ² goodness-of-fit test.